Diabetic Macular Edema Treatment

Diabetic Macular Edema (DME) is a significant cause of vision loss in patients with diabetes and diabetic retinopathy. Although diabetic laser treatment has been the standard treatment for DME for nearly 3o years, there is now important information and data that suggests that better results and vision outcomes can be achieved with Vascular Endothelial Growth Factor (VEGF) Inhibitor injections such as Lucentis® and Eylea® injections.

Research on Diabetic Macular Edema Treatment
According to a report in the American Journal of Ophthalmology in which a thorough analysis of published studies performed on Diabetic Maculopathy from between January 1, 1985 and July 31, 2013 was reviewed, the number of patients with DME gaining an improvement of seeing an additional 10-15 letters on the eye chart was at least 2 times greater for those patients treated with the VEGF inhibitor injections as compared to being treated with laser treatments. Thus, the researchers concluded that VEGF injections such as Lucentis® and Eylea® are superior to laser photocoagulation for treatment of moderate to severe visual impairment caused by DME.

If you or someone you know has diabetes and is concerned about their risk of Diabetic Macular Edema (DME) or Diabetic Retinopathy, it is critical that they have regular dilated eye exams. Please call Center for Sight at 508-730-2020, visit Center for Sight, Google+ or www.facebook.com/centerforsightfallriver.

Center for Sight is conveniently located at 1565 North Main Street, Suite 406, Fall River, Massachusetts 02720 for patients from Massachusetts or Rhode Island.